Thunen Shelley B 4
4 · AEON Biopharma, Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Thunen Shelley B
Director
Transactions
- Award
Class A Common Stock
[F1]2024-08-31+36,021→ 36,021 total - Award
Stock Option
[F2]2024-08-31+96,210→ 96,210 totalExercise: $0.83Exp: 2034-08-30→ Class A Common Stock (96,210 underlying)
Footnotes (2)
- [F1]Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
- [F2]Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
Signature
/s/ Alexander Wilson as attorney-in-fact for Shelley B. Thunen|2024-09-04